Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board

See All Experts

featured

Published in Cardiology and

Journal Scan / Research · March 13, 2024

Angiotensin Receptor/Neprilysin Inhibition in Patients With STEMI vs NSTEMI

Journal of the American College of Cardiology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Douglas Mann MD

Journal of the American College of Cardiology

Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI

J Am Coll Cardiol 2024 Mar 05;83(9)904-914, DL Mann, J Nicolas, B Claggett, ZM Miao, CB Granger, P Kerkar, L Køber, EF Lewis, JJV McMurray, AP Maggioni, J Núñez, M Ntsekhe, JL Rouleau, D Sim, SD Solomon, PG Steg, P van der Meer, E Braunwald, MA Pfeffer, R Mehran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Angiotensin Receptor/Neprilysin Inhibition in Patients With STEMI vs NSTEMI

Additional Info

Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI

Further Reading

Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis

Association Between Delay to First Shock and Successful First-Shock Ventricular Fibrillation Termination in Patients With Witnessed Out-of-Hospital Cardiac Arrest

Comparison of Drug Routes in Out-of-Hospital Cardiac Arrest

Transcatheter Valve Replacement in Severe Tricuspid Regurgitation

Unidirectional Association of Clonal Hematopoiesis With Atherosclerosis Development

TAVR in Patients With Asymptomatic Severe Aortic Stenosis

Prehospital Pulse-Dose Glucocorticoid in Patients With ST-Segment Elevation Myocardial Infarction

The Burden of Diabetes-Associated Multiple Long-Term Conditions on Years of Life Spent and Lost

TAVR in Younger Patients With Severe Aortic Stenosis at Low Surgical Risk: 3-Year Outcomes

Cardiovascular Events Following COVID-19 Vaccination in Adults

Conduction Disturbances and Outcomes After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis

Recently Updated